Clinical Trial Update: Switching of Sildenafil to Riociguat in CTEPH Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating switching chronic thromboembolic pulmonary hypertension patients from sildenafil to riociguat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Thromboembolic Pulmonary Hypertension | Phase 4 | Status: RECRUITING